ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,149,000 | +56.4% | 87,691 | +0.2% | 0.00% | +100.0% |
| Q3 2021 | $5,212,000 | -66.7% | 87,529 | -61.9% | 0.00% | -66.7% |
| Q2 2021 | $15,673,000 | -8.0% | 229,827 | -6.4% | 0.00% | -25.0% |
| Q1 2021 | $17,034,000 | -31.8% | 245,481 | -24.5% | 0.00% | -33.3% |
| Q4 2020 | $24,972,000 | -19.9% | 325,027 | -22.1% | 0.01% | -33.3% |
| Q3 2020 | $31,186,000 | +15.5% | 416,982 | -2.8% | 0.01% | +12.5% |
| Q2 2020 | $26,997,000 | +76.3% | 428,871 | +17.6% | 0.01% | +60.0% |
| Q1 2020 | $15,317,000 | +16.5% | 364,679 | +26.0% | 0.01% | +25.0% |
| Q4 2019 | $13,145,000 | -5.0% | 289,403 | -4.3% | 0.00% | 0.0% |
| Q3 2019 | $13,842,000 | +61.2% | 302,436 | +106.5% | 0.00% | +100.0% |
| Q2 2019 | $8,586,000 | +151.1% | 146,453 | +92.0% | 0.00% | +100.0% |
| Q1 2019 | $3,419,000 | +47.2% | 76,278 | +27.9% | 0.00% | 0.0% |
| Q4 2018 | $2,323,000 | -62.0% | 59,657 | -55.1% | 0.00% | -50.0% |
| Q3 2018 | $6,119,000 | +16.7% | 132,987 | +10.6% | 0.00% | 0.0% |
| Q2 2018 | $5,245,000 | +70.9% | 120,285 | +54.8% | 0.00% | +100.0% |
| Q1 2018 | $3,069,000 | +44.0% | 77,715 | +23.9% | 0.00% | 0.0% |
| Q4 2017 | $2,131,000 | +116.6% | 62,720 | +62.6% | 0.00% | – |
| Q3 2017 | $984,000 | +223.7% | 38,582 | +113.7% | 0.00% | – |
| Q2 2017 | $304,000 | – | 18,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |